Check-Cap (NSDQ:CHEK) said yesterday it inked a development and manufacturing validation deal with GE Healthcare (NYSE:GE) for integrating X-ray source production and assembly into Check-Cap’s indigestible capsule designed for colorectal screening.
The deal comes with the possibility for collaboration on the execution of a high-volume manufactuing facility and distribution of the Check-Cap system after completion of the initial deal, according to Israel-based Check-Cap.
“We are very excited to commence this strategic relationship with GE Healthcare as we continue our efforts to optimize the supply chain for the Check-Cap system. GE Healthcare is a global leader in the development, manufacturing, and distribution of diagnostic imaging agents and radio-pharmaceutical drugs and devices. We believe that leveraging their experience and expertise provides us with a significant opportunity to meet our goal of increasing the time and cost efficiencies of production of our capsule for use in future clinical trials and commercialization,” CEO Bill Densel said in a press release.
Check-Cap said it is currently conducting a multi-center clinical feasibility study and expects to file a CE Mark submission in the 1st half of 2017.
The post Check-Cap partners with GE to dev indigestible X-ray screening capsule appeared first on MassDevice.
from MassDevice http://ift.tt/2aA8vkH
Cap comentari:
Publica un comentari a l'entrada